LARA BIRD: Open Payments
NPI 1952748576 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 41 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $343 · 2025 $851
Food & beverage: $851
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $159 |
| CATALYST PHARMACEUTICALS, INC. | 3 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| Lilly USA, LLC | 3 | $64 |
| CSL Behring | 3 | $56 |
| TG Therapeutics, Inc. | 3 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $46 |
| Genentech USA, Inc. | 2 | $42 |
| Alnylam Pharmaceuticals Inc. | 2 | $41 |
| Eisai Inc. | 2 | $39 |
Products named: Rystiggo, FYCOMPA, Briviact, HYQVIA, AMYVID, Hizentra, BRIUMVI, JOURNAVX.
Industry payments across KY — which companies pay providers there.
